Item 2.02. Results of Operations and Financial Condition.

See Item 7.01- Updated Financial Guidance below, which is incorporated by reference herein.

Item 7.01. Regulation FD Disclosure.





Updated Financial Guidance

On January 10, 2023, AdaptHealth Corp. (the "Company") issued a press release (the "Press Release") announcing certain preliminary performance results for the fourth quarter of 2022 and for the full year ended December 31, 2022 and financial guidance for fiscal year 2023. A copy of the Press Release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information in Item 2.02 and this Item 7.01 (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, regardless of any general incorporation language in such filing, unless expressly incorporated by reference in such filing.

Item 9.01. Financial Statements and Exhibits.





 (d) Exhibits




  99.1     Press Release dated January 10, 2023 announcing certain preliminary
         performance results for the fourth quarter of 2022 and for the full year
         ended December 31, 2022, and financial guidance for fiscal year 2023.
104      Cover Page Interactive Data File (Embedded within the Inline XBRL
         document)




                                     - 2 -

© Edgar Online, source Glimpses